SCHEMBL20370575

SCHEMBL20370575

C=CC(=O)NCCOc1ccc(-c2ccc(-c3ccc(C4CCC(CCCCC)CC4)cc3)c(C)c2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 1/20 0.39
▸ BTK Q06187 1/20 0.36
▸ DGAT1 O75907 2/20 0.36
▸ ITK Q08881 1/20 0.36
▸ ITGB3 P05106 2/20 0.35
▸ ITGA2B P08514 2/20 0.35
▸ MMP2 P08253 2/20 0.35
▸ MMP3 P08254 2/20 0.35
▸ P2RY14 Q15391 1/20 0.35
▸ MMP1 P03956 1/20 0.34
▸ MMP9 P14780 1/20 0.34
▸ MMP14 P50281 1/20 0.34
▸ CYP2C9 P11712 1/20 0.34
▸ HRH3 Q9Y5N1 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ HRH2 P25021 1/20 0.33
▸ HRH1 P35367 1/20 0.33
▸ FFAR4 Q5NUL3 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19855140 0.95 RAB9A (0.39) RAB9ABTKITKITGB3ITGA2B
SCHEMBL20370586 0.92 RAB9A (0.39) RAB9ABTKDGAT1ITKITGB3
SCHEMBL20370465 0.91 RAB9A (0.46) RAB9AITKITGB3ITGA2BCYP2C9
SCHEMBL19855821 0.91 RARB (0.40) RAB9ABTKDGAT1ITKITGB3
SCHEMBL20370590 0.89 RAB9A (0.38) RAB9ABTKDGAT1ITKITGB3
SCHEMBL20370561 0.89 RAB9A (0.44) RAB9AITKITGB3ITGA2BP2RY14
SCHEMBL19856020 0.89 RAB9A (0.48) RAB9AITKITGB3ITGA2BCYP2C9
SCHEMBL19854954 0.88 RAB9A (0.39) RAB9ABTKDGAT1ITKITGB3
SCHEMBL19854969 0.88 ITK (0.41) RAB9ABTKDGAT1ITKCYP2C9
SCHEMBL19853807 0.88 RAB9A (0.47) RAB9AITKITGB3ITGA2BCYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210214615-A1 LIQUID CRYSTAL DISPLAY DEVICE AND DISPLAY UNIT JNC CORPORATION (JP) 2021-07-15 — — US disclosed
US-10662379-B2 Polymerizable polar compound, liquid crystal composition and liquid crystal display device JNC CORPORATION (JP) 2020-05-26 — — US disclosed
US-20180195005-A1 POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORPORATION (JP) 2018-07-12 — — US disclosed
US-20180195005-A1 POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORPORATION (JP) 2018-07-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180195005-A1 POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE SP1, MBD2, PAXBP1 RAB9A 4014/4885BTK 4463/4885DGAT1 4118/4885
US-10662379-B2 Polymerizable polar compound, liquid crystal composition and liquid crystal display device SP1, MBD2, PAXBP1 RAB9A 4014/4885BTK 4463/4885DGAT1 4118/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback